Editorial: Cellular Therapies in Cancer
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02788/full |
id |
doaj-941040870dd743d1996b3bb3e171ab0c |
---|---|
record_format |
Article |
spelling |
doaj-941040870dd743d1996b3bb3e171ab0c2020-11-25T02:05:19ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-11-011010.3389/fimmu.2019.02788510225Editorial: Cellular Therapies in CancerHind Rafei0Rohtesh S. Mehta1Katayoun Rezvani2Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Stem Cell Transplant and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, United StatesDepartment of Stem Cell Transplant and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, United Stateshttps://www.frontiersin.org/article/10.3389/fimmu.2019.02788/fullcellular therapychimeric antigen receptor-T cell therapychimeric antigen receptor-natural killer cell therapyadoptive cell therapyT cellsnatural killer cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hind Rafei Rohtesh S. Mehta Katayoun Rezvani |
spellingShingle |
Hind Rafei Rohtesh S. Mehta Katayoun Rezvani Editorial: Cellular Therapies in Cancer Frontiers in Immunology cellular therapy chimeric antigen receptor-T cell therapy chimeric antigen receptor-natural killer cell therapy adoptive cell therapy T cells natural killer cells |
author_facet |
Hind Rafei Rohtesh S. Mehta Katayoun Rezvani |
author_sort |
Hind Rafei |
title |
Editorial: Cellular Therapies in Cancer |
title_short |
Editorial: Cellular Therapies in Cancer |
title_full |
Editorial: Cellular Therapies in Cancer |
title_fullStr |
Editorial: Cellular Therapies in Cancer |
title_full_unstemmed |
Editorial: Cellular Therapies in Cancer |
title_sort |
editorial: cellular therapies in cancer |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-11-01 |
topic |
cellular therapy chimeric antigen receptor-T cell therapy chimeric antigen receptor-natural killer cell therapy adoptive cell therapy T cells natural killer cells |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.02788/full |
work_keys_str_mv |
AT hindrafei editorialcellulartherapiesincancer AT rohteshsmehta editorialcellulartherapiesincancer AT katayounrezvani editorialcellulartherapiesincancer |
_version_ |
1724938733998833664 |